Abingdon, UK 6/14/11; Taunusstein, Germany 6/14/11—Oxford Instruments has acquired Omicron NanoTechnology and Omniprobe. Based in Frankfurt, Germany, Omicron designs and produces advanced microscopes and chemical analysis instruments for nanotechnology research. Oxford Instruments acquired the company for €32.4 million ($46.5 million = €0.70 = $1) in cash on a cash-free debt-free basis. In 2010, Omicron generated revenues of €37.9 million ($54.1 million) and EBIT of €3.2 million ($4.6 million). Based in Dallas, Texas, Omniprobe designs and produces products that enable probing, manipulation, selective deposition and etch, and sample preparation at the nano-scale for research applications. Omniprobe was acquired for $19.2 million in cash and deferred payments of $0.8 million. In fiscal 2011, Omniprobe had sales of $9.1 million and EBIT of $1.7 million. “I’m delighted with these acquisitions, which augment our growing ability to offer a suite of tools that help our customers benefit from the opportunities offered by nanotechnology,” stated Oxford Instruments Chief Executive Jonathan Flint. The acquisitions are expected to enhance fiscal 2011 adjusted EPS.